Verapamil Reverses Myocardial No-Reflow After Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Verapamil Reverses Myocardial No-Reflow After Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

Published:2013-04-05 Issue:3 Volume:67 Page:911-914
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Fu Qiang,Lu Wen,Huang Yi-jie,Wu Qiang,Wang Lin-guang,Wang Hai-bo,Jiang Shu-zhong,Wang Yan-jiong

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry,General Medicine,Biophysics

Link

http://link.springer.com/content/pdf/10.1007/s12013-013-9581-0.pdf

Reference19 articles.

1. Isaaz, K., Robin, C., Cerisier, A., Lamaud, M., Richard, L., Da, C. A., et al. (2006). A new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention. Coronary Artery Disease, 17, 261–269.

2. Rezkalla, S. H., Dharmashankar, K. C., Abdalrahman, I. B., & Kloner, R. A. (2010). No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. Journal of Interventional Cardiology, 23, 429–436.

3. Lee, C. H., Wong, H. B., Tan, H. C., Zhang, J. J., Teo, S. G., Ong, H. Y., et al. (2005). Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. Journal of Interventional Cardiology, 18, 261–266.

4. Rezkalla, S. H., & Kloner, R. A. (2008). Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheterization & Cardiovascular Interventions, 72, 950–957.

5. Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., et al. (1987). Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation, 76, 142–154.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of microvascular obstruction and intramyocardial hemorrhage in reperfusion injury to the heart;Сибирский научный медицинский журнал;2024-04-26

2. The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data;Reviews in Cardiovascular Medicine;2024-03-14

3. Verapamil inhibits early acute liver failure through suppressing the NLRP3 inflammasome pathway;Journal of Cellular and Molecular Medicine;2021-05-24

4. No-reflow phenomenon in ST-segment elevation myocardial infarction: still the Achilles’ heel of the interventionalist;Future Cardiology;2021-03

5. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction;Heart, Lung and Circulation;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3